PPIL1

peptidylprolyl isomerase like 1, the group of Cyclophilin peptidylprolyl isomerases|Spliceosomal C complex|Spliceosomal B complex|Spliceosomal Bact complex|Spliceosomal P complex

Basic information

Region (hg38): 6:36854827-36874803

Links

ENSG00000137168NCBI:51645OMIM:601301HGNC:9260Uniprot:Q9Y3C6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • pontocerebellar hypoplasia, type 14 (Moderate), mode of inheritance: AR
  • pontocerebellar hypoplasia, type 14 (Strong), mode of inheritance: AR
  • pontocerebellar hypoplasia, type 14 (Moderate), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PPIL1 gene.

  • Inborn_genetic_diseases (14 variants)
  • Pontocerebellar_hypoplasia,_type_14 (12 variants)
  • Congenital_pontocerebellar_hypoplasia (10 variants)
  • not_provided (6 variants)
  • Neurodevelopmental_disorder (1 variants)
  • not_specified (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPIL1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016059.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
3
clinvar
4
missense
7
clinvar
20
clinvar
27
nonsense
1
clinvar
1
start loss
0
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total 0 11 20 3 0

Highest pathogenic variant AF is 0.0000514225

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PPIL1protein_codingprotein_codingENST00000373699 420198
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1210.8561257190291257480.000115
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.580861030.8390.000005811091
Missense in Polyphen2435.2710.68045422
Synonymous0.2013435.50.9570.00000217316
Loss of Function1.9639.550.3146.25e-787

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001190.000119
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.0004170.000416
European (Non-Finnish)0.0001500.000149
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:28502770, PubMed:28076346). PPIases accelerate the folding of proteins. It catalyzes the cis- trans isomerization of proline imidic peptide bonds in oligopeptides (PubMed:16595688). {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:16595688, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.;
Pathway
Spliceosome - Homo sapiens (human);Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA (Consensus)

Intolerance Scores

loftool
0.670
rvis_EVS
0.1
rvis_percentile_EVS
61.28

Haploinsufficiency Scores

pHI
0.0985
hipred
Y
hipred_score
0.719
ghis
0.535

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.754

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ppil1
Phenotype

Gene ontology

Biological process
mRNA splicing, via spliceosome;protein peptidyl-prolyl isomerization;protein folding
Cellular component
nucleus;nucleoplasm;U2-type catalytic step 2 spliceosome;catalytic step 2 spliceosome
Molecular function
peptidyl-prolyl cis-trans isomerase activity;protein binding;cyclosporin A binding;disordered domain specific binding